# Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

> **NCT07467447** · PHASE2 · RECRUITING · sponsor: **Hudson Biotech** · enrollment: 300 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Retatrutide (LY3437943)
- **DRUG:** Placebo
- **BEHAVIORAL:** Standardized diet and physical activity counseling throughout the study.

## Key facts

- **NCT ID:** NCT07467447
- **Lead sponsor:** Hudson Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-15
- **Primary completion:** 2027-03-14
- **Final completion:** 2028-02-17
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07467447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07467447, "Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07467447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*